Soft Tissue Stability in Immediate Implant Placement Using (VST) Versus Conventional Flap in Type II Extraction Sockets
1 other identifier
interventional
16
1 country
1
Brief Summary
This study compare between the vestibular socket therapy (VST) and the traditional mucoperiosteal flap reflection in immediate implant placement in type II extraction socket in the esthetic zone. The technique of vestibular socket therapy (VST), introduced by Elaskry, enables the placement of implants immediately while simultaneously rehabilitating the entire socket, resulting in excellent esthetic and functional outcomes that meet the expectations of patients. VST involves socket augmentation through a minimally invasive vestibular access incision, eliminating the need for the traditional mucoperiosteal flap reflection, regardless of the extent of socket compromise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2023
CompletedFirst Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 22, 2025
August 1, 2025
11 months
December 4, 2023
August 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Soft Tissue Stability
it will be measured digitally using the intraoral scanner. A preoperative scanning, immediate postoperative, 2 months postoperative and 8 months postoperative scanning will be done. Tool to be used: 3shape trios 4 what will be assessed: * gingival recession * loss of interdental papillae height Data will be measured in millimeters
8 months
Secondary Outcomes (1)
Bone Regeneration
8 months
Other Outcomes (1)
Pink Esthetic Score (PES)
8 months
Study Arms (2)
Control group
OTHERControl group will have a full thickness flap, followed by an immediate implant placement using a surgical guide. Then a guided bone regeneration will be achieved by bone graft (autogenous bone chips and xenograft particles and a membrane barrier 1 mm thickness will be applied. The membrane shield then will be stabilized to the apical bone using 2 membrane tacks, customized healing abutment will be connected , then, the elevated flap will be sutured to its original position.
Test group
ACTIVE COMPARATORElaskary Vestibular socket therapy instruments will be used for the intervention, A 1 cm long vestibular access incision at the allocated hopeless tooth will be made at the base of the hopeless tooth to the adjacent teeth. The vestibular pouch will then be dissected in an incisal direction exposing the total socket area and allowing direct access to the socket environment. An immediate implant will be installed using a surgical guide. A membrane shield 1 mm thick will be, trimmed, and tucked through the vestibular access incision starting at 1 mm beyond the socket orifice and reaching to the apical area of the socket. The gap and/ or the defect between the implant body and the shield will then be filled with the same grafting components so the control group. Finally, the vestibular incision will be secured with sutures. The socket will be sealed with a customized healing abutment.
Interventions
Vestibular socket therapy will be used for the intervention.
reflecting the mucoperiosteum to access the extraction socket
Eligibility Criteria
You may qualify if:
- Hopeless maxillary tooth in the esthetic region missing coronal tooth structure
- Type II socket (deficient labial plate of bone and intact overlying soft tissues)
- Adequate palatal bone, ≥ 3 mm apical bone to engage the immediately placed implants
You may not qualify if:
- Smokers
- Pregnant women
- Patients with systemic diseases
- History of chemotherapy or radiotherapy within the past 2 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The British university in Egypt
Cairo, New Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Shawky, BDS
The British University in Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Due to the differences in techniques, the operating surgeon can not be blinded to the procedure
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dentist (BDS)
Study Record Dates
First Submitted
December 4, 2023
First Posted
March 22, 2024
Study Start
October 23, 2023
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP